Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9614 posts found.

Afinitor image

Mixed bag for Novartis and Astellas in breast cancer

December 15, 2014 Research and Development, Sales and Marketing Afinitor, Astellas, Novartis, Xtandi, enzalutamide, everolimus

Preliminary results from a Phase II trial of Astellas’ Xtandi (enzalutamide) show positive benefits for the prostate cancer drug when …
News
Sam Pierce image

Celgene UK: market access is a complex business

December 15, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Abraxane, CDF, Cancer, Celgene, PPRS, Revlimid, market access, sam pierce

Being a firm that specialises in cancer drugs, Celgene UK is no stranger to England’s notoriously rigorous approach to expensive …
Feature
veronica_g

Vermillion takes on two senior heads

December 15, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing david schreiber, vermillion, veronica jordan

US drug development firm Vermillion has appointed Veronica Jordan and David Schreiber to the company’s board of directors.  Dr Veronica …
Appointment
Janssen image

Patient access schemes ‘lack transparency’

December 12, 2014 Research and Development, Sales and Marketing Janssen, NHS, NICE, Velcade, patient access, pharma, scheme

Deals negotiated between the pharma industry and governments to allow patients access to innovative new cancer treatments risk failing because …
News
kevin_sellers_-2011

Unilife appoints comms VP from Intel

December 12, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing kevin sellers, unilife

US developer of injectable drugs Unilife has looked to Intel to appoint a marketing and communications veteran in Kevin Sellers. …
Appointment
Antibiotics image

Antibiotic resistance could kill 10 million a year

December 11, 2014 Research and Development, Sales and Marketing Antibiotics, Cancer, KPMG, Merck, david cameron, rand

Antibiotic-resistant bacteria will kill an extra 10 million people a year by 2050 if the problem is not tackled soon, …
News
Sanofi image

Sanofi looking to diversify, may buy into animal health

December 11, 2014 Manufacturing and Production, Research and Development, Sales and Marketing EFPIA, Jimenez, Sanofi, Serge Weinberg, Viehbacher, animal health

Sanofi is looking to diversify and is even considering buying into the consumer and animal health markets according to its …
News
Takeda image

Takeda eyes new drug licences following positive blood cancer studies

December 11, 2014 Research and Development, Sales and Marketing Adcetris, Takeda, Velcade, ash, bortezomib, brentuximab vedotin, hematology

Takeda is bringing its biotech arm in-house to create a global oncology business unit, which it says will drive forward …
News
Tamoxifen image

Tamoxifen found to reduce breast cancer rates by 30%

December 11, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Arimidex, NICE, anastrozole, astrazenea, breast cancer, tamoxifen

A study from Queen Mary University has demonstrated that tamoxifen can reduce breast cancer rates by around 30% over 20 …
News
kim_lemon

Kim Lemon named head of Liberation Unlimited

December 11, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Creston Health, kim lemon, liberation unlimited

Marketing communications agency Liberation Unlimited has appointed Kim Lemon to head its operations. Since the UK-based comms firm joined the …
Appointment
Onyx pharma image

Treatment shifts away from chemotherapy for multiple myeloma

December 10, 2014 Research and Development, Sales and Marketing Kyprolis, carfilzomib, chemotherapy, myeloma, onyx pharmaceuticals

Results from a Phase III study of a new multiple myeloma offering have found promising results for a treatment that …
News
NHS image

Labour to extend cancer drugs funding if elected

December 10, 2014 Research and Development, Sales and Marketing CDF, Cancer, Labour, NHS, NICE, andy burnham, election

Labour has committed to continuing the Cancer Drugs Fund system under the guise of a new £330 million ‘Cancer Treatment …
News
michel-de-rosen

Pharnext adds industry veteran to board

December 10, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Michel de Rosen, pharnext

France-based clinical stage biopharma firm Pharnext has appointed Michel de Rosen to its board of directors. For nearly 25 years …
Appointment
bayer_healthcare

Mixed results for new leukaemia drugs

December 9, 2014 Research and Development, Sales and Marketing AML, Bayer, Nexavar, Qinprenzo, Sunesis Pharmaceuticals, sorafenib

Two trials of new drugs for acute myeloid leukaemia (AML) have shown promising results in younger and older groups of …
News

Pfizer buys into gene therapy

December 9, 2014 Research and Development, Sales and Marketing London, Pfizer, gene therapy, haemophilia, spark, therapeutics

Pfizer has announced that it is establishing a gene therapy platform as it looks to expand its rare diseases operations. …
News
The Gateway to Local Adoption Series

Latest content

EMA backs plozasiran for rare lipid disorder with high pancreatitis risk

April 27, 2026

Study explores speech as marker in rare neurodegenerative disease

April 27, 2026

Ofichem brings all brands under single trading name

April 23, 2026

Carvolix strengthens its Board of Directors, advisory board and governance structure

April 23, 2026

Under-Secretary of State for Health Innovation and Safety visits new building on University of Huddersfield’s NHIC

April 22, 2026